ES8701178A1 - Procedimiento para preparar derivados de saframicina a - Google Patents

Procedimiento para preparar derivados de saframicina a

Info

Publication number
ES8701178A1
ES8701178A1 ES546574A ES546574A ES8701178A1 ES 8701178 A1 ES8701178 A1 ES 8701178A1 ES 546574 A ES546574 A ES 546574A ES 546574 A ES546574 A ES 546574A ES 8701178 A1 ES8701178 A1 ES 8701178A1
Authority
ES
Spain
Prior art keywords
saframycin
producing
derivatives
novel
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546574A
Other languages
English (en)
Other versions
ES546574A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES8701178A1 publication Critical patent/ES8701178A1/es
Publication of ES546574A0 publication Critical patent/ES546574A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/56—Streptomyces lavendulae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/899—Streptomyces lavendulae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE SAFRAMICINA A DE FORMULA GENERAL (I) Y SALES DE ADICION DE ACIDO, FARMACEUTICAMENTE ACEPTABLES, CON ACIDOS NO TOXICOS Y FISIOLOGICAMENTE BIEN TOLERADOS, COMO CLORHIDRICO, SULFURICO O FOSFORICO O ACIDOS ORGANICOS (CARBOXILICOS Y CARBONICOS INSATURADOS). LA OBTENCION SE EFECTUA POR FERMENTACION; PREPARACION DE UN PRECULTIVO POR INOCULACION DE UN MEDIO DE CULTIVO, QUE CONTIENE UNA FUENTE DE CARBONO Y UNA FUENTE DE NITROGENO Y TRAZAS DE ELEMENTOS ESENCIALES, CON UNA CEPA DEL GENERO STREPTOMYCES CAPAZ DE PRODUCIR SAFRAMICINA A, CULTIVO A TEMPERATURA 25-35JC A PH DE 4,0-7,5, AISLAMIENTO DE LA BIOMASA, ADICION DE UN AMINOACIDO Y DE UN CIANURO AL FILTRADO DE CULTIVO Y PURIFICACION DEL DERIVADO DE SAFRAMICINA A OBTENIDA. ESTOS DERIVADOS SON ANTIBIOTICOS, ANTITUMORALES, CON APLICACION TERAPEUTICA EN HUMANOS Y ANIMALES CON INFECCIONES CAUSADAS POR BACTERIAS, HONGOS Y VIRUS.
ES546574A 1984-08-30 1985-08-30 Procedimiento para preparar derivados de saframicina a Expired ES8701178A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59179292A JPS6158593A (ja) 1984-08-30 1984-08-30 新規サフラマイシンａ誘導体およびその製造法

Publications (2)

Publication Number Publication Date
ES8701178A1 true ES8701178A1 (es) 1986-11-16
ES546574A0 ES546574A0 (es) 1986-11-16

Family

ID=16063271

Family Applications (2)

Application Number Title Priority Date Filing Date
ES546574A Expired ES8701178A1 (es) 1984-08-30 1985-08-30 Procedimiento para preparar derivados de saframicina a
ES555459A Expired ES8800944A1 (es) 1984-08-30 1986-05-29 Procedimiento para preparar derivados de saframicina a.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES555459A Expired ES8800944A1 (es) 1984-08-30 1986-05-29 Procedimiento para preparar derivados de saframicina a.

Country Status (14)

Country Link
US (1) US4837149A (es)
EP (1) EP0173649A3 (es)
JP (1) JPS6158593A (es)
KR (1) KR860002575A (es)
DD (1) DD239611A5 (es)
DK (1) DK391885A (es)
ES (2) ES8701178A1 (es)
FI (1) FI853282L (es)
GR (1) GR852097B (es)
HU (1) HUT41071A (es)
IL (1) IL76242A0 (es)
NO (1) NO853396L (es)
PT (1) PT81037B (es)
ZA (1) ZA856598B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753637A1 (en) 1995-07-13 1997-01-15 Klein Iberica, S.A. Structure for the assembly of sliding doors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0262085A1 (de) * 1986-08-15 1988-03-30 Gesellschaft für Biotechnologische Forschung mbH (GBF) Antibiotika aus Myxococcus
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
AU3956502A (en) 2000-11-03 2002-05-27 Harvard College Saframycins, analogues and uses thereof
US6964804B2 (en) * 2001-02-14 2005-11-15 Shipley Company, L.L.C. Micromachined structures made by combined wet and dry etching
US7183054B2 (en) 2003-06-03 2007-02-27 President And Fellows Of Harvard College Assay for identifying biological targets of polynucleotide-binding compounds
KR100712667B1 (ko) * 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5937952B2 (ja) * 1977-09-12 1984-09-12 正 新井 抗生物質サフラマイシンａ，ｂ，ｃ，ｄ，ｅおよびその製造法
JPS56135486A (en) * 1980-03-26 1981-10-22 Tadashi Arai Antibiotic saframycin s and its preparative method
JPS5942382A (ja) * 1982-09-02 1984-03-08 Yoshitomi Pharmaceut Ind Ltd サフラシン誘導体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753637A1 (en) 1995-07-13 1997-01-15 Klein Iberica, S.A. Structure for the assembly of sliding doors

Also Published As

Publication number Publication date
ES555459A0 (es) 1987-12-01
NO853396L (no) 1986-03-03
EP0173649A3 (en) 1987-08-12
ZA856598B (en) 1986-04-30
KR860002575A (ko) 1986-04-26
GR852097B (es) 1986-01-02
US4837149A (en) 1989-06-06
ES8800944A1 (es) 1987-12-01
FI853282A0 (fi) 1985-08-28
JPS6158593A (ja) 1986-03-25
IL76242A0 (en) 1986-01-31
PT81037A (en) 1985-09-01
EP0173649A2 (en) 1986-03-05
ES546574A0 (es) 1986-11-16
FI853282L (fi) 1986-03-01
HUT41071A (en) 1987-03-30
DK391885D0 (da) 1985-08-29
PT81037B (en) 1987-06-24
DK391885A (da) 1986-03-01
DD239611A5 (de) 1986-10-01

Similar Documents

Publication Publication Date Title
HU9201871D0 (en) Process for the production of 1-methylcarbapenem-derivatives
AU562802B2 (en) Preparation of phosphorus-containing cyanohydrins
EP0198348A3 (en) Process for preparing (+)s-2-hydroxy-2-methyl-hexanoic acid
ES8800944A1 (es) Procedimiento para preparar derivados de saframicina a.
IE882805L (en) Alpha n-alkylated amino acids and dipeptide production
GEP20012438B (en) Process of Preparing α-Methoxyimino-carboxylic Acid Methylamides and Intermediates Used in the Method
MY109628A (en) An improved proces for the preparation of substituted indoline derivatives
CA2098989A1 (en) Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
AU633612B2 (en) Improved process for cyclic amino acid anticonvulsant compounds
HU9400020D0 (en) New process for producing sulphur-derivatives of imidazole, and the obtained new intermediates
HUT52561A (en) Process for production of l-amino acid and aminoacidamids
CA1250832A (en) PREPARATION OF 2-OXINDOLE-1-CARBOXAMIDES; INTERMEDIATE PRODUCTS
AU5193499A (en) Process for the preparation of r-(-)-carnitine
MY109188A (en) Enzymatic process to separate racemic mictures of delta valerolactones
EP0282001A3 (en) Azoxy compounds and process for production thereof
EP0289804A3 (en) Process for preparing optically active mercapto compound
GR3006432T3 (es)
ES8608538A1 (es) Procedimiento para la preparacion de esteres alquilicos de alfa-l-aspartil-l-fenilalanina
CA1273347C (es)
DE3069897D1 (en) Method of preparing 2-oxo- and 2-unsubstituted-hexahydroazepine derivatives
AU2819092A (en) New preparation process for 20-oxo-17alpha,21-dihydroxylated derivatives of pregnane and new intermediates
ES8305326A1 (es) "procedimiento para la preparacion de l-prolina".
ES8706142A1 (es) Un procedimiento para la preparacion de sorbinil
MY105302A (en) Process for dehydrating corticosteroid intermediates.
GB8519264D0 (en) Chemical compounds